Zimmer Biomet Hldgs DL-01

FZIM 
(FSE) 
 
107.00
Updated 14/07/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 0
High 107.00
Low 107.00
Open 107.00
ISIN US98956P1021
Prev close 107.00
# of shares 204.80M
Market cap 21,913M EUR
Intraday

Market closed
Zimmer Biomet Hldgs DL-01
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  107.00 0.0% Stock price unchanged 1.0% Stock price increasing -5.4% Stock price decreasing 15.4% Stock price increasing 9.4% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Smith & Nephew PLC ORD USD0.20 1,754.00 0.7% Stock price increasing 3.0% Stock price increasing 17.8% Stock price increasing 21.3% Stock price increasing 31.7% Stock price increasing 19.8% Stock price increasing
 
Johnson & Johnson 134.71 -4.7% Stock price decreasing -3.8% Stock price decreasing -2.4% Stock price decreasing 5.2% Stock price increasing 8.0% Stock price increasing 4.4% Stock price increasing
 
Stryker Corporation 205.49 -1.7% Stock price decreasing 5.1% Stock price increasing 8.7% Stock price increasing 25.8% Stock price increasing 18.5% Stock price increasing 31.1% Stock price increasing
 
Integra LifeSciences Holdings .. 53.80 -0.4% Stock price decreasing 5.7% Stock price increasing 2.2% Stock price increasing 16.7% Stock price increasing -14.0% Stock price decreasing 19.3% Stock price increasing
 
Astrazeneca PLC 40.22 -1.3% Stock price decreasing 1.4% Stock price increasing 2.3% Stock price increasing 12.4% Stock price increasing 9.7% Stock price increasing 5.9% Stock price increasing
 
Straumann Hldg NA SF 0,10 778.00 0.0% Stock price unchanged 3.6% Stock price increasing 2.8% Stock price increasing 31.9% Stock price increasing 20.5% Stock price increasing 43.8% Stock price increasing

Company profile

Zimmer Biomet Holdings Inc designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.

Peers

Instruments Last Change  
Smith & Neph.. 1,754.00 1.4% Stock price increasing
Johnson & Jo.. 134.71 0.3% Stock price increasing
Stryker Corp.. 205.49 -0.4% Stock price decreasing
Integra Life.. 53.80 -0.8% Stock price decreasing
80,76,58,42,49,38,36,39,25,9
Astrazeneca .. 40.22 0.0% Stock price increasing
Straumann Hl.. 778.00 1.5% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 July 2019 03:55:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB5 - 2019-07-16 04:55:37 - 2019-07-16 03:55:37 - 1000 - Website: OKAY